Mehul Kothari recommends Buy on CAMS, Pfizer; Check Why

According to the technical analyst from Anand Rathi, CAMS can rally to Rs 2,700, while Pfizer can be bought for a target of Rs 4,700.

Markets, bulls, bears, stocks, trading, technicals, market technical, technical analysis
Mehul Kothari Mumbai
1 min read Last Updated : Oct 11 2022 | 8:12 AM IST
BUY
CAMS
Buy Near: Rs 2,520
Target: Rs 2,700
Stop Loss: Rs 2,420

On the daily chart of CAMS we are witnessing a fresh trend line breakout. The breakout has occurred just above the placement of its 200-DEMA and 200-DSMA. In addition, the price action resembles bullish inverse Head & Shoulder pattern.

Also Read


Thus, we advise traders to buy the stock on dips near Rs 2,520 for a target of Rs 2,700 in the coming sessions.

BUY
Pfizer
Buy Above: Rs 4,490
Target: Rs 4,700
Stop Loss: Rs 4,350

After a consolidation of few months, Pfizer has confirmed range breakout and that too above its 200-day moving average. During the process, the stock has managed to confirm a higher top and higher bottom formation which indicates change of trend.

Thus, we advise traders to buy the stock above Rs 4,490 for a target of Rs 4,700 in the coming sessions.

(Mehul Kothari - AVP – Technical Research, Anand Rathi Shares & Stock Brokers. Views are personal).
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CAMSPfizerMarket technicalsMarket OutlookBuzzing stocksstocks to watchStocks to buystocks technical analysistechnical chartsTrading strategies

Next Story